BusinessStudy Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat® Proteomic TestBy Nasdaq OMXSep 20, 2017, 3:18 PM UTC
BusinessNew Data Show Biodesix’s VeriStrat® Test is Cost-Saving, Improves Survival and Quality of Life in Advanced Lung-Cancer PatientsBy Nasdaq OMXApr 3, 2017, 5:08 PM UTC